ACTA1 and head and neck squamous cell carcinoma: CAF-focused IMC panels have been validated in the context of breast cancer and head and neck squamous cell carcinoma (HNSCC), resulting in the identification of distinct CAF subtypes, expressing different levels of αSMA and FAP (Fibroblast Activation Protein) (31, 99).